EVALUATION OF A MOPP-TYPE REGIMEN IN HISTIOCYTOSIS-X - SOUTHWEST ONCOLOGY GROUP STUDY

  • 1 January 1977
    • journal article
    • research article
    • Vol. 61  (5) , 855-859
Abstract
The overall 38% response rate in histocytosis X for cyclophosphamide, vincristine (Oncovin), prednisone and procarbazine was not superior to responses that can be achieved with the component single agents. This is in contrast to the higher response rates that can be achieved by the combination of these agents in Hodgkin''s disease. This is the 2nd study of combination chemotherapy with individually effective agents that failed to improve the response rates in histiocytosis patients with poor prognostic indicators.

This publication has 2 references indexed in Scilit: